These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 36018754)

  • 1. An overview of vitamins as epidrugs for colorectal cancer prevention.
    Boughanem H; Kompella P; Tinahones FJ; Macias-Gonzalez M
    Nutr Rev; 2023 Mar; 81(4):455-479. PubMed ID: 36018754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nutritive vitamins as epidrugs.
    Nur SM; Rath S; Ahmad V; Ahmad A; Ateeq B; Khan MI
    Crit Rev Food Sci Nutr; 2021; 61(1):1-13. PubMed ID: 32023132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenomic effects of vitamin D in colorectal cancer.
    Khayami R; Goltzman D; Rabbani SA; Kerachian MA
    Epigenomics; 2022 Oct; 14(19):1213-1228. PubMed ID: 36325830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of vitamins and dietary pattern on epigenetic modification of non-communicable diseases.
    Khajebishak Y; Alivand M; Faghfouri AH; Moludi J; Payahoo L
    Int J Vitam Nutr Res; 2023 Aug; 93(4):362-377. PubMed ID: 34643416
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of epigenetics in colorectal cancer.
    Coppedè F
    Expert Rev Gastroenterol Hepatol; 2014 Nov; 8(8):935-48. PubMed ID: 24871610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Vitamins in DNA Methylation as Dietary Supplements or Neutraceuticals: A Systematic Review.
    Fareed MM; Ullah S; Qasmi M; Shityakov S
    Curr Mol Med; 2023; 23(10):1012-1027. PubMed ID: 36200195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetics and its therapeutic potential in colorectal cancer.
    Oryani MA; Tavasoli A; Ghalavand MA; Ashtiani RZ; Rezaee A; Mahmoudi R; Golvari H; Owrangi S; Soleymani-Goloujeh M
    Epigenomics; 2022 Jun; 14(11):683-697. PubMed ID: 35473313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetics of colorectal cancer.
    Migheli F; Migliore L
    Clin Genet; 2012 Apr; 81(4):312-8. PubMed ID: 22263639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the road to colorectal cancer development: crosstalk between the gut microbiota, metabolic reprogramming, and epigenetic modifications.
    Chen A; Jiang Z; Cai L; Tang D
    Carcinogenesis; 2023 Dec; 44(8-9):631-641. PubMed ID: 37586059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of epigenetic modifications in Colorectal Cancer Metastasis.
    Su R; Wu X; Tao L; Wang C
    Clin Exp Metastasis; 2022 Aug; 39(4):521-539. PubMed ID: 35429301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D intake is negatively associated with promoter methylation of the Wnt antagonist gene DKK1 in a large group of colorectal cancer patients.
    Rawson JB; Sun Z; Dicks E; Daftary D; Parfrey PS; Green RC; Gallinger S; McLaughlin JR; Wang PP; Knight JA; Bapat B
    Nutr Cancer; 2012; 64(7):919-28. PubMed ID: 22966878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioactive Vitamins and Epigenetic Modifications in Diabetes: A Perspective.
    Găman MA; Cozma EC; Srichawla BS; Cozma MA; Varkaneh HK; Chen Y; Găman AM; Diaconu CC
    Curr Diabetes Rev; 2024; 20(1):e300323215239. PubMed ID: 37005542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring Potential Epigenetic Biomarkers for Colorectal Cancer Metastasis.
    Ajithkumar P; Vasantharajan SS; Pattison S; McCall JL; Rodger EJ; Chatterjee A
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers.
    Okugawa Y; Grady WM; Goel A
    Gastroenterology; 2015 Oct; 149(5):1204-1225.e12. PubMed ID: 26216839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic biomarkers of colorectal cancer: Focus on DNA methylation.
    Coppedè F
    Cancer Lett; 2014 Jan; 342(2):238-47. PubMed ID: 22202641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-translational histone modifications in circulating nucleosomes as new biomarkers in colorectal cancer.
    Gezer U; Holdenrieder S
    In Vivo; 2014; 28(3):287-92. PubMed ID: 24815828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic biomarkers in colorectal cancer: premises and prospects.
    Zamani M; Hosseini SV; Mokarram P
    Biomarkers; 2018 Mar; 23(2):105-114. PubMed ID: 27788596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Research progress of DNA methylation in colorectal cancer (Review).
    Wang Y; Wang C; Zhong R; Wang L; Sun L
    Mol Med Rep; 2024 Sep; 30(3):. PubMed ID: 38963030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation and chromatin modifiers in colorectal cancer.
    Vymetalkova V; Vodicka P; Vodenkova S; Alonso S; Schneider-Stock R
    Mol Aspects Med; 2019 Oct; 69():73-92. PubMed ID: 31028771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accumulation of aberrant DNA methylation during colorectal cancer development.
    Sakai E; Nakajima A; Kaneda A
    World J Gastroenterol; 2014 Jan; 20(4):978-87. PubMed ID: 24574770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.